These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27579330)

  • 41. Elevated serum levels of Interleukin-37 are associated with inflammatory cytokines and disease activity in rheumatoid arthritis.
    Yang L; Zhang J; Tao J; Lu T
    APMIS; 2015 Dec; 123(12):1025-31. PubMed ID: 26547368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating cytokine pattern and factors describing rheumatoid arthritis: IL-15 as one of the biomarkers for RA?
    Pavkova Goldbergova M; Pavek N; Lipkova J; Jarkovsky J; Stouracova M; Gatterova J; Vasku A; Soucek M; Nemec P
    Biomarkers; 2012 Nov; 17(7):655-62. PubMed ID: 22998011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors.
    Jørgensen KT; Wiik A; Pedersen M; Hedegaard CJ; Vestergaard BF; Gislefoss RE; Kvien TK; Wohlfahrt J; Bendtzen K; Frisch M
    Ann Rheum Dis; 2008 Jun; 67(6):860-6. PubMed ID: 17644543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis.
    Xiangyang Z; Lutian Y; Lin Z; Liping X; Hui S; Jing L
    Cytokine; 2012 Apr; 58(1):6-9. PubMed ID: 22239947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-MBL autoantibodies in patients with rheumatoid arthritis: prevalence and clinical significance.
    Gupta B; Raghav SK; Agrawal C; Chaturvedi VP; Das RH; Das HR
    J Autoimmun; 2006 Sep; 27(2):125-33. PubMed ID: 16904869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis].
    Cho SY; Kang SY; Lee HJ; Lee WI
    Korean J Lab Med; 2008 Feb; 28(1):39-45. PubMed ID: 18309254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients.
    García-Berrocal B; González C; Pérez M; Navajo JA; Moreta I; Dávila C; González-Buitrago JM
    Clin Chim Acta; 2005 Apr; 354(1-2):123-30. PubMed ID: 15748608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of serum angiopoietin-1 measurement in the diagnosis of early rheumatoid arthritis.
    Ishikawa A; Okada J; Nishi K; Hirohata S
    Clin Exp Rheumatol; 2011; 29(4):604-8. PubMed ID: 21906428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Significance of citrullinated collagen type II and its antibodies in rheumatoid arthritis].
    Tian X; Bi LQ; Li ZG
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(33):2334-8. PubMed ID: 17156630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
    Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
    Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
    De Rycke L; Verhelst X; Kruithof E; Van den Bosch F; Hoffman IE; Veys EM; De Keyser F
    Ann Rheum Dis; 2005 Feb; 64(2):299-302. PubMed ID: 15166003
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic utility of the Elecsys anti-CCP assay in patients with rheumatoid arthritis.
    Ye H; Chen F; Yan S; Zhang Y; Fang Z; Su X; Cai W; Zhang Z
    Mod Rheumatol; 2014 Jul; 24(4):580-4. PubMed ID: 24252038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.
    Jansen AL; van der Horst-Bruinsma I; van Schaardenburg D; van de Stadt RJ; de Koning MH; Dijkmans BA
    J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients.
    Zhu T; Feng L
    Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis.
    El-Banna H; Jiman-Fatani A
    BMC Musculoskelet Disord; 2014 Nov; 15():379. PubMed ID: 25406539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis].
    Xie QB; Yin G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile.
    Spadaro A; Rinaldi T; Riccieri V; Taccari E; Valesini G
    Clin Exp Rheumatol; 2002; 20(2):213-6. PubMed ID: 12051401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic laboratory markers of joint damage in rheumatoid arthritis.
    Lindqvist E; Eberhardt K; Bendtzen K; Heinegård D; Saxne T
    Ann Rheum Dis; 2005 Feb; 64(2):196-201. PubMed ID: 15458956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autoantibodies in early rheumatoid arthritis: Brasília cohort: results of a three-year serial analysis.
    da Mota LM; Santos Neto LL; Pereira IA; Burlingame R; Ménard HA; Laurindo IM
    Rev Bras Reumatol; 2011 Dec; 51(6):564-71. PubMed ID: 22124591
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Antibodies to cyclic citrullinized peptide in rheumatoid arthritis].
    Aleksandrova EN; Chemeris NA; Karateev DE; Novikov AA; Brodetskaia KA; Nasonov EL
    Ter Arkh; 2004; 76(12):64-8. PubMed ID: 15724930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.